Delayed Hemolytic Anemia after Treatment with Artesunate: Case Report and Literature Review.

CONCLUSION: Considering clinical course and base on a reliable causality assessment scale, post artesunate delay hemolytic anemia was possible.
PMID: 30411691 [PubMed - as supplied by publisher]

Source: Current Drug Safety - November 9, 2018 Category: Drugs & Pharmacology Authors: Salehi M, Masoumi-Asl H, Assarian M, Rad NK, Haghi AM, Nikbakht M, Khalili H Tags: Curr Drug Saf Source Type: research